Overview

The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Fever can develop after fiberoptic bronchoscopy (FB) in about 2.5 - 16 % of adult patients. We evaluated the impact of oral amoxicillin/clavulanate (AC) on incidence of postbronchoscopic fever and pneumonia.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Anti-Bacterial Agents
Clavulanic Acid
Clavulanic Acids